Drug–Drug Interactions That Are Often Missed in Long-Term Workers' Compensation Claims


Introduction

As workers' compensation claims become more complex and prolonged, medication regimens often become more complicated as well. Injured workers may receive prescriptions from multiple providers over months or even years, increasing the risk of polypharmacy and potentially significant drug–drug interactions (DDIs).

While some interactions are widely recognized, others may be overlooked because they involve medications prescribed for unrelated conditions, are managed by different providers, or develop gradually over time. These interactions can contribute to adverse events, reduced treatment effectiveness, delayed recovery, and increased healthcare utilization. Identifying and managing these risks remains an important component of medication oversight in long-term workers' compensation claims. [1,2]

Why Drug–Drug Interactions Are Common in Long-Term Claims

Workers with chronic claims frequently receive treatment not only for their work-related injury, but also for conditions such as:

  • Hypertension

  • Depression and anxiety

  • Diabetes

  • Cardiovascular disease

  • Sleep disturbances

As medications are added over time, the likelihood of clinically significant interactions increases. Because many of these therapies are prescribed by different providers, potentially important interactions may not always be immediately recognized. [1,2]


SSRIs/SNRIs and NSAIDs

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly prescribed for depression, anxiety, and chronic pain conditions.

Examples include:

  • Sertraline

  • Escitalopram

  • Fluoxetine

  • Duloxetine

  • Venlafaxine

When combined with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or diclofenac, the risk of gastrointestinal bleeding may increase. SSRIs and SNRIs can affect platelet function, while NSAIDs may increase gastrointestinal irritation and bleeding risk. [3,4]


NSAIDs and Antihypertensive Medications

NSAIDs can interact with several commonly prescribed blood pressure medications, including:

  • ACE inhibitors, such as:

    • Lisinopril

    • Enalapril

    • Benazepril

    • Ramipril

  • Angiotensin II receptor blockers (ARBs), such as:

    • Losartan

    • Valsartan

    • Irbesartan

    • Olmesartan

When taken together, NSAIDs can make some blood pressure medications less effective. This may result in reduced blood pressure control and, in some patients, increase the risk of acute kidney injury, particularly with long-term NSAID use or in individuals who already have underlying kidney disease or hypertension. [5]


Anticoagulants and NSAIDs

Another commonly overlooked interaction involves NSAIDs and anticoagulants.

Examples include:

  • Warfarin + ibuprofen

  • Apixaban + naproxen

  • Rivaroxaban + diclofenac

Both medication classes can independently increase bleeding risk. When used together, the potential for gastrointestinal bleeding and other bleeding complications may increase significantly. [6]


Looking Beyond Individual Prescriptions

Many clinically significant drug interactions develop over time as medications are added by multiple providers treating different conditions.

For this reason, medication reviews should focus on the entire medication profile, not just medications related to the work injury. Injured workers may be taking treatments for chronic conditions such as hypertension, depression, or cardiovascular disease that can influence treatment safety and recovery outcomes.

A comprehensive medication review can help identify drug–drug interactions, duplicate therapies, and medication-related risks that might otherwise go unnoticed, supporting safer treatment and better overall outcomes. [1,2]



By Sarah Cirildo, PharmD

For questions, e-mail pharmd@prodigyrx.com


Citations

1.  Agency for Healthcare Research and Quality. Medication Reconciliation. Updated 2025. Accessed October 2026. https://psnet.ahrq.gov/primer/medication-reconciliation 

2. American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in medication reconciliation. Am J Health Syst Pharm. 2013;70(5):453-456. doi:10.2146/sp130001.  https://academic.oup.com/ajhp/article/70/5/453/5112731 

3. de Abajo FJ, García-Rodríguez LA. Risk of upper gastrointestinal bleeding and perforation associated with selective serotonin reuptake inhibitors and venlafaxine therapy. Arch Gen Psychiatry. 2008;65(7):795-803. doi:10.1001/archpsyc.65.7.795. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482766 

4. Jiang HY, Chen HZ, Hu XJ, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):42-50.e3. doi:10.1016/j.cgh.2014.06.021. https://www.sciencedirect.com/science/article/abs/pii/S1542356514009276 

5. Johnson AG. The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs. J Clin Hypertens (Greenwich). 1997;1(2):91-97. Accessed October 27, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC8101828/ 

6. Vinogradova Y, Coupland C, Hippisley-Cox J, et al. Outcomes of oral anticoagulation with concomitant NSAID use: a registry based cohort study. Blood. 2023;142(suppl 1):5129. Accessed October 27, 2026. https://ashpublications.org/blood/article/142/Supplement_1/5129/500513/Outcomes-of-Oral-Anticoagulation-with-Concomitant 

‍
Next
Next

California Drug Policy Updates: Three Pharmacy Changes to Watch in 2027